Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
COVID-19 and the digestive system lesions in children
https://doi.org/10.21508/1027-4065-2022-67-5-6-17
Abstract
Initially, doctors did not pay much attention to gastrointestinal symptoms in patients with COVID-19. Fever and respiratory syndrome were monitored. A more prolonged observation period revealed gastrointestinal disorders to be an important element of the new coronavirus infection. In scientific publications, a stable term appeared — gastrointestinal coronavirus disease 2019. The tropism of the SARS-CoV-2 virus to the epitheliocytes of the gastrointestinal tract, the presence and long-term persistence of the virus in the feces were found. The frequent detection of gastrointestinal symptoms in infected patients, the frequent involvement of the liver and pancreas in the pathological process determine the importance of clinical and laboratory assessment of the state of the digestive system due to its undoubted impact on the status, course, and the overall disease prognosis. Based on the analysis of scientific publications, the article presents the results of the latest observations regarding the development of a new disease, its diagnosis, treatment options using modern drugs when combined with dyspeptic syndrome and other gastroenterological symptoms. The role of the use of standards, in particular the clinical recommendations of the Ministry of Health of Russia, is emphasized.
About the Authors
K. I. Grigoriev
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
L. A. Kharitonova
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
References
1. Industry profile of the International Labor Organization. (in Russ). https://www.ilo.org/wcmsp5/groups/ public/---ed_dialogue/---sector/documents/briefingnote/wcms_747870.pdf/ Ссылка активна на 13.07.2022.
2. Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous primeboost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 2021; 397(10275): 671-681. DOI: 10.1016/S0140-6736(21)00234-8
3. Shatunova P.O., Bykov A.S., Svitich O.A., Zverev V.V. Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19. Zhurnal mikrobiologii, èpidemiologii i immunobiologii 2020; 97(4): 339-345. (in Russ.) DOI: 10.36233/0372-9311-2020-97-4-6
4. Namazova-Baranova L.S., Sadeki N.M.Ya., Efendieva K.E. New Evidence on the Evolution of the COVID-19 Pandemic: A Literature Review. Рediatricheskaya farmakologiya 2021; 18(4): 314-319. (in Russ.) DOI: 10.15690/pf.v18i4.2299
5. Nikiforov V.V., Suranova T.G., Mironov A.Yu., Zabozlaev F.G. New coronavirus infection (COVID-19): etiology, epidemiology, clinic, diagnosis, treatment and prevention. M.: Academy of Postgraduate Education FGBU, 2020; 48 p. (in Russ.)
6. Osmanov I.M., Mazankova L.N., Samitova E.R., Borzakova S.N., Vinokurov A.V., Miroshina A.V. New coronavirus infection (COVID-19) in children. Рraktika pediatra 2021; 3:8-11. (in Russ.)
7. Martin B., DeWitt P.E., Russell S., Anand A., Bradwell K.R., Bremer C. et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. JAMA Netw Open 2022; 5(2): e2143151. DOI: 10.1001/jamanetworkopen.2021.43151
8. Xu K., Cai H., Shen Y., Ni Q., Chen Y., Hu S. et al. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020; 49(1): 147-157. DOI: 10.3785/j.issn.1008-9292
9. Deidda S., Tora L., Firinu D., Del Giacco S., Campagna M., Meloni F. et al. Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management. Expert Rev Gastroenterol Hepatol. 2021; 15(1): 41-50. DOI: 10.1080/17474124.2020.1821653
10. Ungaro R.C., Sullivan T., Colombel J.F., Patel G. What Should Gastroenterologists and Patients Know About COVID-19? Clin Gastroenterol Hepatol 2020; 18: 1409-1411. DOI: 10.1016/j.cgh.2020.03.020
11. Tian Y., Rong L., Nian W., He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51: 843-851. DOI: 10.1111/apt.15731
12. Mao R., Qiu Y., He J., Tan J., Li X., Liang J. et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 667-678. DOI:10.1016/S2468-1253(20)30126-6
13. Shakmaeva M.A., Chernova T.M., Timchenko V.N., Nachinkina T.A., Tetyushin K.V., Kaplina T.A. et al. Features of a new coronavirus infection in children of different ages. Detskiye infektsii 2021; 20(2): 5-9. (in Russ.) DOI: 10.22627/2072-8107-2021-20-2-5-9
14. Cao T.-T., Zhang G.-Q., Pellegrini E., Zhao Q., Li J., Luo L.-J., Pan H.-Q. COVID-19 and its effects on the digestive system. World J Gastroenterol 2021; 27(24): 3502-3515. DOI: 10.3748/wjg.v27.i24.3502
15. Martynova G.P., Stroganova M.A., Bogvilene Ya.A., Akhmetova V.A., Belkina A.B., Kolodina A.A. Clinical and epidemiological features of the new coronavirus infection COVID-19 in children in Krasnoyarsk. Lecheniye i profilaktika 2021; 11(1): 5-11. (in Russ.)
16. Ermolenko K.D., Gonchar N.V., Skripchenko N.V. The defeat of the organs of the gastrointestinal tract with a new coronavirus infection in children. Pediatriya im. G.N. Speranskogo 2020; 99(6): 135-140. (in Russ.) DOI: 10.24110/0031-403X-2020-99-6-135-140
17. Shehab M., Alrashed F., Shuaibi S., Alajmi D., Barkun A. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol 2021; 8(1): e000571. DOI: 10.1136/bmjgast-2020-000571
18. Kharitonova L.A., Osmanov I.M., Ploskireva A.A., Solodovnikova O.N., Milova Yu.E. Lesions of the digestive system in children with Covid-19. Eksperimental’naya i klinicheskaya gastroenterologiya 2021; 185(1): 53-66. (in Russ.) DOI: 10.31146/1682-8658-ecg-185-1-53-668
19. Shchikota A.M., Pogonchenkova I.V., Turova E.A., Rassulova M.A., Filippov M.S. The defeat of the gastrointestinal tract, liver and pancreas with COVID-19. Dokazatel’naya gastroenterologiya 2021; 10(1): 30-37. (in Russ.) DOI: 10.17116/dokgastro2021100113
20. Popova R.V., Ruzhentsova T.A., Khavkina D.A., Chukhlyaev P.V., Garbuzov A.A., Meshkova N.A. Gastrointestinal disorders in children with COVID-19. Problemy osobo opasnykh infektsiy 2020; 3: 154-157. (in Russ.) DOI: 10.21055/0370-1069-2020-3-154-157
21. [Sheptulin A.A. Diarrhea in patients with COVID-19 infection. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2020; 30(6): 51-56. (in Russ.) DOI: 10.22416/1382-4376-2020-30-6-51-56
22. Noviello D., Costantino A., Muscatello A., Bandera A., Consonni D., Vecchi M., Basilisko G. Functional gastrointestinal and somatoform symptoms four month after SARS-CoV-2 infection: A controlled cohort study. Neurogastroenterol Motil 2021; e14187. DOI: 10.1111/nmo.14187
23. Belmer S.V., Khavkin A.I., Pechkurov D.V. Functional disorders of the digestive system in children. Principles of diagnosis and treatment (international and domestic recommendations). Moscow: GEOTAR-Media, 2020; 224 p. (in Russ.)
24. Feklina Ia.Yu., Mnatsakanyan M.G., Pogromov A.P., Tashchyаn O.V. Irritable Bowel Syndrome Onset after New Coronavirus Infection COVID-19. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii 2021; 31(6): 23-28. (in Russ.) DOI: 10.22416/1382-4376-2021-31-6-23-28
25. Mordasova V.I., Kopylova D.V., Podstavkina I.S., Ponomareva E.N., Timchenko I.V. Gastrointestinal tract captured by COVID-19: the impact of a new coronavirus infection on the course and outcomes of diverticular disease of the colon. Effektivnaya farmakoterapiya 2022; 18(14): 24-27. (in Russ.) DOI: 10.33978/2307-3586-2022-18-14-24-27
26. Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv. 2020 February 4. DOI: 10.1101/2020.02.03.931766
27. Kayaaslan B., Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023. DOI: 10.4254/wjh.v13.i12.2013
Review
For citations:
Grigoriev K.I., Kharitonova L.A. COVID-19 and the digestive system lesions in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(5):6-17. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-5-6-17
Views:
357
Email this article 